Celemics, Inc. (KOSDAQ:331920)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Life Science and Medicine-related Product	4.56B
Life Science and Medicine-related Product Growth	40.16%
Analysis Service	2.15B
Analysis Service Growth	-1.54%
Other	8.56M
Other Growth	-69.05%
Other	8.56M
Other Growth	-69.05%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Other	842.47M
Other Growth	-20.11%
South Korea	4.60B
South Korea Growth	-7.37%
Europe	1.28B
Europe Growth	129.07%
Other	842.47M
Other Growth	-20.11%